The NPR/PBS NewsHour/Marist poll finds most sports fans are against indoor sports during the pandemic. NPR's David Greene talks to Jane McManus, director of Marist's Center for Sports Communication.
The FDA will vote on whether to clear Pfizer's COVID-19 vaccine for emergency use. Two lawsuits question how Facebook got so big. Plus, lawmakers on Capitol Hill debate a COVID-19 relief package.
If Pfizer's vaccine wins authorization, about 44,000 doses will be administered to Department of Defense individuals in a first round of shots that will shed light on any distribution issues.
Claire Hannan, head of the Association of Immunization Managers, says the officials planning vaccine distribution face plenty of challenges. One is not knowing how many doses are coming their way.
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
The corporate consulting giant issued a rare apology for its behind-the-scenes work with Purdue Pharma, maker of OxyContin. One senator called McKinsey's behavior "abhorrent."
The vaccine produced by Pfizer and BioNTech is the first to be authorized by Canadian health officials. The decision makes Canada just the third country in the world to grant such an authorization.